TABLE-Genmab Q3 losses deepen yr/yr
Nov 10 (Reuters) - Three months to end-September
(millions of Danish crowns unless stated)
Q3 2009 Q3 2008 Revenue 87 390 Operating loss -210 -37 Net loss -90 -36
NOTES - The full name of the Danish biotech company is
Gebmab A/S (GEN.CO).
(Reported by Copenhagen Newsroom)
© Thomson Reuters 2009 All rights reserved



